![](https://static.theprint.in/wp-content/uploads/2023/06/theprint_default_image_new.jpg)
Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high
HYDERABAD/BENGALURU (Reuters) -Cipla, India’s third-largest generics drugmaker by sales, posted first-quarter profit above expectations on Friday as it garnered higher sales in its North America market, boosting its shares to an all-time high. The …